(Q38430373)

3 September 2017

1 reference

title

New insights on Parkinson's disease genes: the link between mitochondria impairment and neuroinflammation (English)

1 reference

3 September 2017

0 references

1 reference

Dorit Trudler

1

1 reference

3 September 2017

Yuval Nash

series ordinal

2

1 reference

3 September 2017

Dan Frenkel

series ordinal

3

1 reference

3 September 2017

publication date

17 April 2015

1 reference

Journal of Neural Transmission

3 September 2017

published in

1 reference

3 September 2017

volume

122

1 reference

3 September 2017

issue

10

1 reference

3 September 2017

page(s)

1409-1419

1 reference

The role of pathogenic DJ-1 mutations in Parkinson's disease.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Expanding insights of mitochondrial dysfunction in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Expression of DJ-1 in the adult mouse CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Localization of LRRK2 to membranous and vesicular structures in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Classic and new animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

PINK1 function in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkin deficiency increases vulnerability to inflammation-related nigral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

PINK1 protein in normal human brain and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

A mitocentric view of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

DJ-1 binds to mitochondrial complex I and maintains its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Genetics of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Deciphering the role of heterozygous mutations in genes associated with parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Free radicals in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkinson's disease: from monogenic forms to genetic susceptibility factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Microglial responses to dopamine in a cell culture model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Epidemiology of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Glial reactions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

LRRK2 inhibition attenuates microglial inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitochondrial involvement in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitochondrial dysfunction and oxidative damage in parkin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Complex I deficiency in Parkinson's disease frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

The PINK1/Parkin pathway regulates mitochondrial morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitogen-activated protein kinases in mammalian oxidative stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Preconditioning to mild oxidative stress mediates astroglial neuroprotection in an IL-10-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Selective microglial activation in the rat rotenone model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

The role of alpha-synuclein in both neuroprotection and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

The genetics of Parkinson's disease: progress and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Reactive astrocytes in neural repair and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

DJ-1 has a role in antioxidative stress to prevent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Regulation of LRRK2 expression points to a functional role in human monocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkinson's disease: from molecular pathways in disease to therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Pink1 suppresses alpha-synuclein-induced phenotypes in a Drosophila model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitochondrial disorders as windows into an ancient organelle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

PINK1-dependent recruitment of Parkin to mitochondria in mitophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Understanding the molecular causes of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Genetic basis of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitochondrial fission, fusion, and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1399-Z

Glial cells and Parkinson's disease.

21 January 2018

1 reference

12 December 2020

Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action

1 reference

12 December 2020

Knocking out DJ-1 attenuates astrocytes neuroprotection against 6-hydroxydopamine toxicity

1 reference

12 December 2020

Differences in antimicrobial susceptibility in Escherichia coli from Canadian intensive care units based on regional and demographic variables.

1 reference

12 December 2020

Environment, mitochondria, and Parkinson's disease

1 reference

12 December 2020

Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system

1 reference

12 December 2020

Mitochondria in the etiology and pathogenesis of Parkinson's disease

1 reference

12 December 2020

Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations

1 reference

12 December 2020

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

1 reference

12 December 2020

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.

1 reference

12 December 2020

Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients

1 reference

12 December 2020

PINK1 stimulates interleukin-1β-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1

1 reference

12 December 2020

Elevated TRAF2/6 expression in Parkinson's disease is caused by the loss of Parkin E3 ligase activity.

1 reference

12 December 2020

10.1007/S00702-015-1399-Z

Identifiers

DOI

1 reference

3 September 2017

1 reference